X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,082 | -43.8% | 10,167 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $19,724 | +146.6% | 10,167 | +930.1% | 0.00% | – |
| Q1 2021 | $8,000 | +33.3% | 987 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | -14.3% | 987 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -22.2% | 987 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | -10.0% | 987 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $10,000 | -9.1% | 987 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | -15.4% | 987 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $13,000 | +1200.0% | 987 | +1442.2% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 64 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |